Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-289579
Filing Date
2014-07-31
Accepted
2014-07-31 16:01:56
Documents
10
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d744928d10q.htm 10-Q 598018
2 EX-31.1 d744928dex311.htm EX-31.1 7777
3 EX-31.2 d744928dex312.htm EX-31.2 7774
4 EX-32.1 d744928dex321.htm EX-32.1 5304
  Complete submission text file 0001193125-14-289579.txt   3863558

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT glyc-20140630.xml EX-101.INS 463326
6 XBRL TAXONOMY EXTENSION SCHEMA glyc-20140630.xsd EX-101.SCH 35930
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE glyc-20140630_cal.xml EX-101.CAL 39495
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE glyc-20140630_def.xml EX-101.DEF 151408
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20140630_lab.xml EX-101.LAB 303188
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20140630_pre.xml EX-101.PRE 219091
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36177 | Film No.: 141006248
SIC: 2834 Pharmaceutical Preparations